Huma raised €73M in a Series D+ round in Jul 2024. The company is based in UK. Investors in the round: AstraZeneca, Hat Technology Fund, Hitachi Ventures and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
